StonvexLoading…
StonvexStonvexStonvexCore line items from RJF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $15.91B | $14.92B | $12.99B | $11.31B |
Operating Income | Not available | Not available | $2.28B | $2.02B |
Net Income | $2.13B | $2.07B | $1.74B | $1.51B |
EPS (Diluted) | $10.30 | $9.70 | $7.97 | $6.98 |
Total Assets | $88.23B | $82.99B | $78.36B | $80.95B |
Total Liabilities | $75.73B | $71.33B | $68.17B | $71.52B |
Cash & Equivalents | $11.39B | $11.00B | $9.31B | $6.18B |
Free Cash Flow OCF − CapEx | $2.25B | $1.95B | $-3.69B | $-19.00M |
Shares Outstanding | 198.14M | 203.29M | 208.80M | 215.10M |